المؤلفون: Fabrizio Michetti, Gabriele Di Sante, Maria Elisabetta Clementi, Federica Valeriani, Martina Mandarano, Francesco Ria, Rosa Di Liddo, Mario Rende, Vincenzo Romano Spica

المصدر: International Journal of Molecular Sciences, Vol 25, Iss 2, p 776 (2024)

مصطلحات موضوعية: S100B protein, adipose tissue, obesity, diabetes, Biology (General), QH301-705.5, Chemistry, QD1-999

العلاقة: https://www.mdpi.com/1422-0067/25/2/776Test; https://doaj.org/toc/1661-6596Test; https://doaj.org/toc/1422-0067Test; https://doaj.org/article/8954160015cc4cd59cf0561d1c3ea8b9Test

الإتاحة: https://doi.org/10.3390/ijms25020776Test
https://doaj.org/article/8954160015cc4cd59cf0561d1c3ea8b9Test

المؤلفون: Guo Yutao, Huang Chujun, Zhang Libin, Lin Mingxiang

المصدر: Xin yixue, Vol 54, Iss 7, Pp 506-510 (2023)

مصطلحات موضوعية: autoimmune encephalitis, child, s100b protein, early stage, diagnosis, Medicine

وصف الملف: electronic resource

العلاقة: https://www.xinyixue.cn/fileup/0253-9802/PDF/1691564054428-2101675776.pdfTest; https://doaj.org/toc/0253-9802Test

الوصول الحر: https://doaj.org/article/d7c4f34abab24fe29b76dd6861564bb1Test

المؤلفون: Guan Jin, Yanhao Yang, Feng Bi, Mingyan Yang, Yinhua Ma

المصدر: Folia Neuropathologica, Vol 61, Iss 1, Pp 47-52 (2023)

مصطلحات موضوعية: traumatic brain injury, serotonin, s100b protein, cognitive impairment, diagnostic efficiency, Medicine

وصف الملف: electronic resource

العلاقة: https://www.termedia.pl/5-HT-and-S100-values-in-evaluating-severity-of-cognitive-impairment-after-traumatic-brain-injury,20,50153,1,1.htmlTest; https://doaj.org/toc/1641-4640Test; https://doaj.org/toc/1509-572XTest

الوصول الحر: https://doaj.org/article/bc2c7a1520834ea2b48ac979e9ba5ec8Test

المؤلفون: Li Y, Chen X, Zhou R, Xu W, Wang X, Chao W, Xue S

المصدر: Neuropsychiatric Disease and Treatment, Vol Volume 19, Pp 209-217 (2023)

مصطلحات موضوعية: progressive ischemic stroke, cognition impairment, homocysteine, s100b protein, Neurosciences. Biological psychiatry. Neuropsychiatry, RC321-571, Neurology. Diseases of the nervous system, RC346-429

وصف الملف: electronic resource

العلاقة: https://www.dovepress.com/correlation-between-cognitive-impairment-and-homocysteine-andTest-s100b-pr-peer-reviewed-fulltext-article-NDT; https://doaj.org/toc/1178-2021Test

الوصول الحر: https://doaj.org/article/dc9755339dae48e7a31f04ead9452ea1Test

المؤلفون: Rakesh Jalali, Izabela Godlewska, Magdalena Fadrowska-Szleper, Agata Pypkowska, Adam Kern, Jacek Bil, Joanna Manta, Jerzy Romaszko

المصدر: Journal of Personalized Medicine, Vol 13, Iss 12, p 1724 (2023)

مصطلحات موضوعية: emergency department, traumatic brain injury (TBI), S100B protein, alcohol, diagnostic process, Medicine

وصف الملف: electronic resource

العلاقة: https://www.mdpi.com/2075-4426/13/12/1724Test; https://doaj.org/toc/2075-4426Test

الوصول الحر: https://doaj.org/article/35c92d05bc0242b2b43d16bdd76a1843Test

المؤلفون: Tomasz Kozlowski, Weronika Bargiel, Maksymilian Grabarczyk, Maria Skibinska

المصدر: Brain Sciences, Vol 13, Iss 9, p 1334 (2023)

مصطلحات موضوعية: S100B protein, schizophrenia, major depressive disorder, bipolar disorder, depression, autistic spectrum disorder, Neurosciences. Biological psychiatry. Neuropsychiatry, RC321-571

وصف الملف: electronic resource

العلاقة: https://www.mdpi.com/2076-3425/13/9/1334Test; https://doaj.org/toc/2076-3425Test

الوصول الحر: https://doaj.org/article/f3e3b98cad2b4f38be3296556aabc880Test

المؤلفون: Lyudmila A. Levchuk, Olga V. Roschina, Ekaterina V. Mikhalitskaya, Elena V. Epimakhova, German G. Simutkin, Nikolay A. Bokhan, Svetlana A. Ivanova

المصدر: Journal of Personalized Medicine, Vol 13, Iss 9, p 1423 (2023)

مصطلحات موضوعية: depressive disorders, depressive episode, recurrent depressive disorder, proteins of nerve tissue damage, S100B protein, myelin basic protein, Medicine

وصف الملف: electronic resource

العلاقة: https://www.mdpi.com/2075-4426/13/9/1423Test; https://doaj.org/toc/2075-4426Test

الوصول الحر: https://doaj.org/article/b7d189d7efb7442cbd9e39de49ab1577Test

المؤلفون: Fabrizio Michetti, Maria Elisabetta Clementi, Rosa Di Liddo, Federica Valeriani, Francesco Ria, Mario Rende, Gabriele Di Sante, Vincenzo Romano Spica

المصدر: International Journal of Molecular Sciences; Volume 24; Issue 11; Pages: 9605

مصطلحات موضوعية: S100B protein, pathogenic factor

جغرافية الموضوع: agris

وصف الملف: application/pdf

العلاقة: Molecular Neurobiology; https://dx.doi.org/10.3390/ijms24119605Test

الإتاحة: https://doi.org/10.3390/ijms24119605Test

المؤلفون: O. A. Grebenchikov, A. K. Evseev, V. V. Kulabuchov, A. N. Kuzovlev, S. S. Petrikov, G. R. Ramazanov, Sh. Gh. Khusainov, R. A. Cherpakov, A. K. Shabanov, A. I. Spichko, О. А. Гребенчиков, А. К. Евсеев, В. В. Кулабухов, А. Н. Кузовлев, С. С. Петриков, Г. Р. Рамазанов, Ш. Ж. Хусаинов, Р. А. Черпаков, А. К. Шабанов, А. И. Шпичко

المصدر: Russian Sklifosovsky Journal "Emergency Medical Care"; Том 11, № 4 (2022); 561-572 ; Журнал им. Н.В. Склифосовского «Неотложная медицинская помощь»; Том 11, № 4 (2022); 561-572 ; 2541-8017 ; 2223-9022

مصطلحات موضوعية: белок S100b, neuroprotection, ischemic stroke, consciousness, neurological disorders, S100b protein, нейропротекция, ишемический инсульт, сознание, неврологические нарушения

وصف الملف: application/pdf

العلاقة: https://www.jnmp.ru/jour/article/view/1513/1232Test; Chen Y, Wright N, Guo Y, Turnbull I, Kartsonaki C, Yang L, et al. Mortality and recurrent vascular events after first incident stroke: a 9year community-based study of 0·5 million Chinese adults. Lancet Glob Health. 2020;8(4):e580–e590. PMID: 32199124 https://doi.org/10.1016/S2214-109XTest(20)30069-3; GBD 2016 Causes of Death Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1151–1210. PMID: 28919116 https://doi.org/10.1016/S0140-6736Test(17)32152-9; Xing C, Arai K, Lo EH, Hommel M. Pathophysiologic cascades in ischemic stroke. Int J Stroke. 2012;7(5):378–385. PMID: 22712739 https://doi.org/10.1111/j.1747-4949.2012.00839.xTest; Шамалов Н.А., Стаховская Л.В., Клочихина О.А., Полунина О.С., Полунина Е.А. Анализ динамики основных типов инсульта и патогенетических вариантов ишемического инсульта. Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуски. 2019;119(3–2):5– 10. https://doi.org/10.17116/jnevro20191190325Test; Donkor ES. Stroke in the 21st Century: A Snapshot of the Burden, Epidemiology, and Quality of Life. Stroke Res Treat. 2018;2018:3238165. PMID: 30598741 https://doi.org/10.1155/2018/3238165Test; Paul S, Candelario-Jalil E. Emerging neuroprotective strategies for the treatment of ischemic stroke: An overview of clinical and preclinical studies. Exp Neurol. 2021;335:113518. PMID: 33144066 https://doi.org/10.1016/j.expneurol.2020.113518Test; Острова И.В., Гребенчиков О.А., Голубева Н.В. Нейропротективное действие хлорида лития на модели остановки сердца у крыс. Общая реаниматология. 2019;15(3):73–82. https://doi.org/10.15360/18139779-2019-3-73-82Test; Chamorro Á, Meisel A, Planas AM, Urra X, van de Beek D, Veltkamp R. The immunology of acute stroke. Nat Rev Neurol. 2012;8(7):401–410. PMID: 22664787 https://doi.org/10.1038/nrneurol.2012.98Test; Veltkamp R, Gill D. Clinical Trials of Immunomodulation in Ischemic Stroke. Neurotherapeutics. 2016;13(4):791–800. PMID: 27412685 https://doi.org/10.1007/s13311-016-0458-yTest; Wilhelm S, Ma D, Maze M, Franks NP. Effects of xenon on in vitro and in vivo models of neuronal injury. Anesthesiology. 2002;96(6):1485–1491. PMID: 12170064 https://doi.org/10.1097/00000542-200206000-00031Test; David HN, Leveille F, Chazalviel L, MacKenzie ET, Buisson A, Lemaire M, et al. Reduction of ischemic brain damage by nitrous oxide and xenon. J Cereb Blood Flow Metab. 2003;23(10):1168-1173. PMID: 14526227 https://doi.org/10.1097/01.WCB.0000087342.31689.18Test; Alam A, Suen KC, Hana Z, Sanders RD, Maze M, Ma D. Neuroprotection and neurotoxicity in the developing brain: an update on the effects of dexmedetomidine and xenon. Neurotoxicol Teratol. 2017;60:102–116. PMID: 28065636 https://doi.org/10.1016/j.ntt.2017.01.001Test; Laitio R, Hynninen M, Arola O, Virtanen S, Parkkola R, Saunavaara J, et al. Effect of Inhaled Xenon on Cerebral White matter Damage in Comatose Survivors of Out-of-Hospital Cardiac Arrest: A Randomized Clinical Trial. JAMA. 2016;315(11):1120–1128. PMID: 26978207 https://doi.org/10.1001/jama.2016.1933Test; Maze M, Laitio T. Xenon limits brain damage following cardiac arrest. ICU Management & Practice. 2018;18(special suppl. 3 Shock):192–195.; Гребенчиков О.А., Шабанов А.К., Николаев Л.Л., Шпичко А.И., Братищев И.В., Марченко Л.Ю., и др. Влияние ксенона на провоспалительную активацию и апоптоз нейтрофилов человека в условиях ex vivo. Журнал им. Н.В. Склифосовского «Неотложная медицинская помощь». 2021;10(3):511–520. https://doi.org/10.23934/2223-90222021-10-3-511-520Test; Кузовлев А.Н., Шпичко А.И., Рыжков И.А., Гребенчиков О.А., Шабанов А.К., Хусаинов Ш.Ж., и др. Влияние ксенона на фосфорилирование киназы гликогенсинтазы-3ẞ и антиоксидантные ферменты в мозге крыс. Журнал им. Н.В. Склифосовского Неотложная медицинская помощь. 2020;9(4):564–572. https://doi.org/10.23934/2223-90222020-9-4-564-57213Test; Filev AD, Silachev DN, Ryzhkov IA, Lapin KN, Babkina AS, Grebenchikov OA, et al. Effect of Xenon Treatment on Gene Expression in Brain Tissue after Traumatic Brain Injury in Rats. Brain Sci. 2021;11(7):889. PMID: 34356124 https://doi.org/10.3390/brainsci11070889Test; Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet. 1974;2(7872):81–84. PMID: 4136544 https:// doi.org/10.1016/s0140-6736(74)91639-0; Wijdicks EF, Bamlet WR, Maramattom BV, Manno EM, McClelland RL. Validation of a new coma scale: The FOUR score. Ann Neurol. 2005;58(4):585–593. PMID: 16178024 https://doi.org/10.1002/ana.20611Test; Goldstein LB, Bertels C, Davis JN. Interrater reliability of the NIH stroke scale. Arch Neurol. 1989;46(6):660–662. PMID: 2730378 https://doi.org/10.1001/archneur.1989.00520420080026Test; Черпаков Р.А., Гребенчиков О.А. Влияние концентрации хлорида лития на его нейропротекторные свойства при ишемическом инсульте у крыс. Общая реаниматология. 2021;17(5):101–110. https://doi.org/10.15360/1813-9779-2021-5-101-110Test; Gill M, Martens K, Lynch EL, Salih A, Green SM. Interrater reliability of 3 simplified neurologic scales applied to adults presenting to the emergency department with altered levels of consciousness. Ann Emerg Med. 2007;49(4):403–407. PMID: 17141146 https://doi.org/10.1016/j.annemergmed.2006.03.031Test; Fischer M, Rüegg S, Czaplinski A, Strohmeier M, Lehmann A, Tschan F, et al. Inter-rater reliability of the Full Outline of UnResponsiveness score and the Glasgow Coma Scale in critically ill patients: a prospective observational study. Crit Care. 2010;14(2):R64. PMID: 20398274 https://doi.org/10.1186/cc8963Test; Saika A, Bansal S, Philip M, Devi BI, Shukla DP. Prognostic value of FOUR and GCS scores in determining mortality in patients with traumatic brain injury. Acta Neurochir (Wien). 2015;157(8):1323–1328. PMID: 26077394 https://doi.org/10.1007/s00701-015-2469-6Test; Brott T, Adams HP Jr, Olinger CP, Marler JR, Barsan WG, Biller J, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke. 1989;20(7):864–870. PMID: 2749846 https://doi.org/10.1161/01.str.20.7.864Test; Garavelli F, Ghelfi AM, Kilstein JG. Usefulness of NIHSS score as a predictor of non-neurological in-hospital complications in stroke. Med Clin (Barc). 2021;157(9):434–437. PMID: 33069388 https://doi.org/10.1016/j.medcli.2020.07.034Test; Wu Q, Tang AJ, Zeng L, Niu SZ, Tian MM, Jin AP, et al. Prognosis of Neurological Improvement in Inpatient Acute Ischemic Stroke Survivors: A Propensity Score Matching Analysis. J Stroke Cerebrovasc Dis. 2021;30(1):105437 PMID: 33197800 https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.105437Test; Tatebayashi K, Yoshimura S, Sakai N, Uchida K, Kageyama H, Yamagami H, et al. Relationship Between Acute Neurological Function and Long-Term Prognosis in Patients with Large Arterial Occlusions. J Stroke Cerebrovasc Dis. 2021;30(4):105625. PMID: 33497935 https://doi.org/10.1016/j.jstrokecerebrovasdis.2021.105625Test; Wu Z, Zeng M, Li C, Qiu H, Feng H, Xu X, et al. Time-dependence of NIHSS in predicting functional outcome of patients with acute ischemic stroke treated with intravenous thrombolysis. Postgrad Med J. 2019;95(1122):181–186. PMID: 30975729 https://doi.org/10.1136/postgradmedj-2019-136398Test; Abraha HD, Butterworth RJ, Bath PM, Wassif WS, Garthwaite J, Sherwood RA. Serum S-100 protein, relationship to clinical outcome in acute stroke. Ann Clin Biochem. 1997;34( Pt 5):546–550. PMID: 9293311 https://doi.org/10.1177/000456329703400510Test; Fassbender K, Schmidt R, Schreiner A, Fatar M, Mühlhauser F, Daffertshofer M, et al. Leakage of brain-originated proteins in peripheral blood: temporal profile and diagnostic value in early ischemic stroke. J Neurol Sci. 1997;148(1):101–105. PMID: 9125396 https://doi.org/10.1016/s0022-510xTest(96)05351-8; Foerch C, Otto B, Singer OC, Neumann-Haefelin T, Yan B, Berkefeld J, et al. Serum S100B predicts a malignant course of infarction in patients with acute middle cerebral artery occlusion. Stroke. 2004;35(9):2160–2164. PMID: 15297628 https://doi.org/10.1161/01.STR.0000138730.03264.acTest; Lasek-Bal A, Jedrzejowska-Szypulka H, Student S, Warsz-Wianecka A, Zareba K, Puz P, et al. The importance of selected markers of inflammation and blood-brain barrier damage for short-term ischemic stroke prognosis. J Physiol Pharmacol. 2019;70(2). PMID: 31356182 https://doi.org/10.26402/jpp.2019.2.04Test; Foerch C, Wunderlich MT, Dvorak F, Humpich M, Kahles T, Goertler M, et al. Elevated serum S100B levels indicate a higher risk of hemorrhagic transformation after thrombolytic therapy in acute stroke. Stroke. 2007;38(9):2491–2495. PMID: 17673718 https://doi.org/10.1161/STROKEAHA.106.480111Test; Michetti F, D’Ambrosi N, Toesca A, Puglisi MA, Serrano A, Marchese E, et al. The S100B story: from biomarker to active factor in neural injury. J Neurochem. 2019;148(2):168–187. PMID: 30144068 https://doi.org/10.1111/jnc.14574Test; Singh V, Roth S, Veltkamp R, Liesz A. HMGB1 as a Key Mediator of Immune Mechanisms in Ischemic Stroke. Antioxid Redox Signal. 2016;24(12):635–651. PMID: 26493086 https://doi.org/10.1089/ars.2015.6397Test; Elting JW, de Jager AE, Teelken AW, Schaaf MJ, Maurits NM, van der Naalt J, et al. Comparison of serum S-100 protein levels following stroke and traumatic brain injury. J Neurol Sci. 2000;181(1–2):104–110. PMID: 11099719 https://doi.org/10.1016/s0022-510xTest(00)00442-1; Woldegerima N, Rosenblatt K, Mintz CD. Neurotoxic Properties of Propofol Sedation Following Traumatic Brain Injury. Crit Care Med. 2016;44(2):455–456. PMID: 26771796 https://doi.org/10.1097/CCM.00000000000Test; https://www.jnmp.ru/jour/article/view/1513Test

الإتاحة: https://doi.org/10.23934/2223-9022-202211-4-561-572Test
https://doi.org/10.1016/S2214-109XTest(20)30069-3
https://doi.org/10.1016/S0140-6736Test(17)32152-9
https://doi.org/10.1111/j.1747-4949.2012.00839.xTest
https://doi.org/10.17116/jnevro20191190325Test
https://doi.org/10.1155/2018/3238165Test
https://doi.org/10.1016/j.expneurol.2020.113518Test
https://doi.org/10.15360/18139779-2019-3-73-82Test
https://doi.org/10.1038/nrneurol.2012.98Test
https://doi.org/10.1007/s13311-016-0458-yTest

المؤلفون: T. M. Poponina, K. I. Gunderina, Yu. S. Poponina, V. V. Ryabov, Т. М. Попонина, К. И. Гундерина, Ю. С. Попонина, В. В. Рябов

المصدر: The Siberian Journal of Clinical and Experimental Medicine; Том 38, № 2 (2023); 82-88 ; Сибирский журнал клинической и экспериментальной медицины; Том 38, № 2 (2023); 82-88 ; 2713-265X ; 2713-2927

مصطلحات موضوعية: мозгоспецифический белок S100B, affective disorders, S100B protein, аффективные расстройства

وصف الملف: application/pdf

العلاقة: https://www.sibjcem.ru/jour/article/view/1789/815Test; Vaduganathan M., Mensah G.A., Turco J.V., Fuster V., Roth G.A. The global burden of cardiovascular diseases and risk: A compass for future health. J. Am. Coll. Cardiol. 2022;80(25):2361–2371. DOI:10.1016/j.jacc.2022.11.005.; Марков В.А., Максимов И.В., Рябов В.В., Репин А.Н., Вышлов Е.В., Попонина Т.М. и др. Разработка и внедрение новых методов лечения острого коронарного синдрома. Сибирский медицинский журнал. 2007;22(3):10–15.; Пантелеев О.О., Рябов В.В. Делирий у больного инфарктом миокарда. Сибирский журнал клинической и экспериментальной медицины. 2022;37(3):49–55. DOI:10.29001/2073-8552-2022-37-3-49-55.; Wu Q., Kling J.M. Depression and the risk of myocardial infarction and coronary death. A meta-analysis of prospective cohort studies. Medicine. 2016;95(6):e2815–e2819. DOI:10.1097/MD.0000000000002815.; Michetti F., D’Ambrosi N., Toesca A., Puglisi M.A., Serrano A., Marchese E. et al. The S100B story: from biomarker to active factor in neural injury. J. Neurochem. 2019;148(2):168–187. DOI:10.1111/jnc.14574.; Janigro D., Mondello S., Posti J.P., Unden J. GFAP and S100B: What you always wanted to know and never dared to ask. Front. Neurol. 2022;13:835597. DOI:10.3389/fneur.2022.835597.; Zigmond A.S., Snaith R.P. The hospital anxiety and depression scale. Acta. Psychiatr. Scan. 1983;67(6):361–370. DOI:10.1111/j.1600-0447.1983.tb09716.x.; Попонина Т.М., Гундерина К.И., Попонина Ю.С., Солдатенко М.В. Влияние агомелатина на показатели вариабельности ритма сердца у больных с тревожно-депрессивными расстройствами, перенесших острый коронарный синдром. Сибирский медицинский журнал. 2018;33(3):36–45. DOI:10.29001/2073-8552-2018-33-3-36-45.; Попонина Т.М., Гундерина К.И., Попонина Ю.С., Марков В.А. Оценка психического статуса и его коррекция агомелатином у больных острым коронарным синдромом. Бюллетень сибирской медицины. 2013;12(6):48–53. DOI:10.20538/1682-0363-2013-6-48-53.; Folstein M.F., Folstein S.E., McHugh P.R. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975;12(3):189–198. DOI:10.1016/0022-3956(75)90026-6.; Sheehan D.V. The Sheehan patient rated anxiety scale. J. Clin. Psychiatry. 1999;60(Suppl. 18):63–64.; Beck A.T., Beck R.W. Screening depressed patients in family practice. A rapid technic. Postgraduate Medicine. 1972;52(6):81–85. DOI:10.1080/00325481.1972.11713319.; Poponina T., Gunderina K., Poponina Y. The level of brain-specific protein S100B in patients with acute coronary syndrome associated with anxiety-depressive disorders. Eur. Heart J. Acute Cardiovascular Care. 2021;10(Suppl_1):zuab020.108. DOI:10.1093/ehjacc/zuab020.108.; Czeiter E., Amrein K., Gravesteijn B.Y., Lecky F., Menon D.K., Mondello S. et al. Blood biomarkers on admission in acute traumatic brain injury: Relations to severity, CT findings and care path in the CENTER-TBI study. EBioMedicine. 2020;56:102785. DOI:10.1016/j.ebiom.2020.102785.; Herrmann M., Vos P., Wunderlich M.T., de Bruijn C.H., Lamers J.K. Release of glial tissue-specific proteins after acute stroke: a comparative analysis of serum concentrations of protein S-100B and glial fibrillary acidic protein. Stroke. 2000;31(11):2670–2677. DOI:10.1161/01.STR.31.11.2670.; Perrin P., Collongues N., Baloglu S., Bedo D., Bassand X., Lavaux T. et al. Cytokine release syndrome-associated encephalopathy in patients with COVID-19. Eur. J. Neurol. 2021;28(1):248–258. DOI:10.1111/ene.14491.; Wang F., Zou Z.-R., Yuan D., Gong Y., Zhang L., Chen X. et al. Correlation between serum S100β protein levels and cognitive dysfunction in patients with cerebral small vessel disease: a case-control study. Biosci. Rep. 2017;37(2):BSR20160446. DOI:10.1042/BSR20160446.; Лебедева Е.В., Горохов А.С., Счастный Е.Д., Репин А.Н., Симуткин Г.Г., Шишнева Е.В. и др. Динамика когнитивной дисфункции и биохимического маркера повреждения ЦНС S100ß при коронарном шунтировании. Бюллетень сибирской медицины. 2018;17(4):72–84. DOI:10.20538/1682-0363-2018-4-72-84.; Arora P., Sagar R., Mehta M., Pallavi P., Sharma S., Mukhopadhyay A.K. Serum S100ß levels in patients with depression. Indian J. Psychiatry. 2019;61(1):70–76. DOI:10.4103/psychiatry.IndianJPsychiatry_391_16.; Shen Z., Cui L., Mou S., Ren L., Yuan Y., Shen X. et al. Combining S100B and cytokines as neuro-inflammatory biomarkers for diagnosing generalized anxiety disorder: A proof-of-concept study based on machine learning. Front. Psychiatry. 2022;13:881241. DOI:10.3389/fpsyt.2022.881241.; https://www.sibjcem.ru/jour/article/view/1789Test

الإتاحة: https://doi.org/10.29001/2073-8552-2023-38-2-82-88Test
https://doi.org/10.1016/j.jacc.2022.11.005Test
https://doi.org/10.29001/2073-8552-2022-37-3-49-55Test
https://doi.org/10.1097/MD.0000000000002815Test
https://doi.org/10.1111/jnc.14574Test
https://doi.org/10.3389/fneur.2022.835597Test
https://doi.org/10.1111/j.1600-0447.1983.tb09716.xTest
https://doi.org/10.29001/2073-8552-2018-33-3-36-45Test
https://doi.org/10.20538/1682-0363-2013-6-48-53Test
https://doi.org/10.1016/0022-3956Test(75)90026-6